Pulsus is the publisher of peer reviewed scientific, technical, and medical journals and magazines. Since establishment 1984, has been instrumental in healthcare and medical dissemination. Pulsus expanded with the support from scientific societies and open its arm to conduct global medical and healthcare meetings. With immense please and support, Pulsus is proud to announce 13th International Conference on Clinical Gastroenterology and Hepatology, to be held during December 07-08, 2017 in Madrid, Spain.
The global gastrointestinal endoscopy market is expected to reach $47 billion by 2020 approximately, according to a report by IQ4I Research & Consultancy. This year, roughly 20 million individuals experience the ill effects of no less than one digestive issue, which may cost $18 billion in medicinal services expenses, and a huge number of individuals, will die pointlessly. The market is estimated to grow at a compound annual growth rate of around 7 per cent from 2014 to 2020. The major drivers for the market growth are increase in cancer, diabetes and obesity patients, aging population as well as a rise in patient's preference for minimal invasive surgeries. The Gastroenterology and Hepatology segment commanded the largest market in 2013. North America accounts for the largest market share with increase in gastrointestinal endoscopic treatment options and obese population followed by Europe and Japan. However, there is also a growing demand for the gastrointestinal endoscopy market in the emerging countries such as India and China. Some of the leading players in the market include Johnson and Johnson, Olympus Corporation and Covidien.
Digestive diseases are debilitating and expensive. They trouble our social insurance framework with critical cost and adversely affect our economy. Hold times are growing while assets are shrinking. A noteworthy extent of digestive sickness is preventable and quite a bit of it is treatable, especially if diagnosed early. Given the disturbing rate at which digestive ailments are expanding, the ground-breaking and regularly crushing effect digestive malady has on individual’s remains to a great extent undervalued. In the last five years, we led more than 180 trials in gastroenterological signs including more than 167,000 patients at roughly 6,400 locales.
Pulsus is a publisher of scientific, technical, and medical journals. Pulsus established in 1984, headquartered in London, UK and with its offices in Ontario, Canada and Hyderabad, India. Pulsus acquired Andrew John openaccessjournas.com and Publishing to expand publishing and conducting global medical meetings under cmesociety.com banner. Endorsed by medical societies, Pulsus Group is an ardent supporter of international medical research, and publishes both national and International journals in association with medical and scientific societies.